Santhera is readying some news in the Spring timeframe and I've drawn out some targets. Next target up is 20% from the current level. I have been accumulating.
In full disclosure, I have a son who would benefit from success of Santhera products - which is why I am aware of this company at this time. I am not in any way or any other way associated with this company.
If you are willing to accumulate and hold we are nearing the all-time low. After a cost restructuring 02-Nov, 2020 - the next key point is 2Q 2021. Regardless of the news reported in Q2, as we get closer there will be more interest in this company that may offer a unique opportunity for patient investors. Given the possibility of a volatile market during this same...
